» Articles » PMID: 31443997

Acute Kidney Injury from Sepsis: Current Concepts, Epidemiology, Pathophysiology, Prevention and Treatment

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2019 Aug 25
PMID 31443997
Citations 521
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis-associated acute kidney injury (S-AKI) is a frequent complication of the critically ill patient and is associated with unacceptable morbidity and mortality. Prevention of S-AKI is difficult because by the time patients seek medical attention, most have already developed acute kidney injury. Thus, early recognition is crucial to provide supportive treatment and limit further insults. Current diagnostic criteria for acute kidney injury has limited early detection; however, novel biomarkers of kidney stress and damage have been recently validated for risk prediction and early diagnosis of acute kidney injury in the setting of sepsis. Recent evidence shows that microvascular dysfunction, inflammation, and metabolic reprogramming are 3 fundamental mechanisms that may play a role in the development of S-AKI. However, more mechanistic studies are needed to better understand the convoluted pathophysiology of S-AKI and to translate these findings into potential treatment strategies and add to the promising pharmacologic approaches being developed and tested in clinical trials.

Citing Articles

Beneficial Effects of Butyrate on Kidney Disease.

Diep T, Liu H, Yan L Nutrients. 2025; 17(5).

PMID: 40077642 PMC: 11901450. DOI: 10.3390/nu17050772.


S-nitrosoglutathione inhibits pyroptosis of kidney tubular epithelial cells in sepsis via the SIRT3/SOD2/mtROS signaling pathway.

Fan H, Sun M, Zhu J Ren Fail. 2025; 47(1):2472987.

PMID: 40050253 PMC: 11892043. DOI: 10.1080/0886022X.2025.2472987.


Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury.

Chen L, Deng Y, Hu J, Gong X Front Pharmacol. 2025; 16:1539886.

PMID: 40046749 PMC: 11880292. DOI: 10.3389/fphar.2025.1539886.


Sepsis subphenotypes: bridging the gaps in sepsis treatment strategies.

Zhang X, Zhang W, Zhang H, Liao X Front Immunol. 2025; 16:1546474.

PMID: 40013154 PMC: 11862915. DOI: 10.3389/fimmu.2025.1546474.


MTHFD2 stabilizes LOX expression through RNA methylation modification to promote sepsis-induced acute kidney injury progression.

Sun S, Han B, Ren G, Fan L, Sun J, Li H Hum Cell. 2025; 38(2):62.

PMID: 40009304 DOI: 10.1007/s13577-025-01189-9.


References
1.
Uchino S, Kellum J, Bellomo R, Doig G, Morimatsu H, Morgera S . Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294(7):813-8. DOI: 10.1001/jama.294.7.813. View

2.
Tu Y, Wang H, Sun R, Ni Y, Ma L, Xv F . Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Ren Fail. 2014; 36(10):1559-63. DOI: 10.3109/0886022X.2014.949764. View

3.
Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G . Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J. 2004; 50(1):102-9. DOI: 10.1097/01.mat.0000104846.27116.ea. View

4.
Frenette A, Bouchard J, Bernier P, Charbonneau A, Nguyen L, Rioux J . Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care. 2014; 18(6):602. PMC: 4256900. DOI: 10.1186/s13054-014-0602-1. View

5.
Lankadeva Y, Kosaka J, Evans R, Bellomo R, May C . Urinary Oxygenation as a Surrogate Measure of Medullary Oxygenation During Angiotensin II Therapy in Septic Acute Kidney Injury. Crit Care Med. 2017; 46(1):e41-e48. DOI: 10.1097/CCM.0000000000002797. View